| The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an … F Musarrat, V Chouljenko, A Dahal, R Nabi, T Chouljenko, SD Jois, ... Journal of medical virology 92 (10), 2087-2095, 2020 | 181 | 2020 |
| Adjuvanting a simian immunodeficiency virus vaccine with toll-like receptor ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection … SP Kasturi, PA Kozlowski, HI Nakaya, MC Burger, P Russo, M Pham, ... Journal of virology 91 (4), 10.1128/jvi. 01844-16, 2017 | 84 | 2017 |
| Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques C Petitdemange, SP Kasturi, PA Kozlowski, R Nabi, CF Quarnstrom, ... JCI insight 4 (4), 2019 | 61 | 2019 |
| Virus-like particles displaying trimeric simian immunodeficiency virus (SIV) envelope gp160 enhance the breadth of DNA/modified vaccinia virus Ankara SIV vaccine-induced … SS Iyer, S Gangadhara, B Victor, X Shen, X Chen, R Nabi, SP Kasturi, ... Journal of virology 90 (19), 8842-8854, 2016 | 42 | 2016 |
| Vaccine-elicited mucosal and systemic antibody responses are associated with reduced simian immunodeficiency viremia in infant rhesus macaques K Jensen, R Nabi, KKA Van Rompay, S Robichaux, JD Lifson, M Piatak Jr, ... Journal of virology 90 (16), 7285-7302, 2016 | 31 | 2016 |
| Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy R Nabi, Z Moldoveanu, Q Wei, ET Golub, HG Durkin, RM Greenblatt, ... PLoS One 12 (7), e0180245, 2017 | 28 | 2017 |
| Intramuscular vaccination of mice with the human herpes simplex virus type-1 (HSV-1) VC2 vaccine, but not its parental strain HSV-1 (F) confers full protection against lethal … SK Naidu, R Nabi, NR Cheemarla, BA Stanfield, PJ Rider, ... PLoS One 15 (2), e0228252, 2020 | 24 | 2020 |
| Strong, but age-dependent, protection elicited by a deoxyribonucleic acid/modified vaccinia Ankara simian immunodeficiency virus vaccine V Chamcha, S Kannanganat, S Gangadhara, R Nabi, PA Kozlowski, ... Open forum infectious diseases 3 (1), ofw034, 2016 | 21 | 2016 |
| Novel oncolytic herpes simplex virus 1 VC2 promotes long-lasting, systemic anti-melanoma tumor immune responses and increased survival in an immunocompetent B16F10-derived … IK Uche, N Fowlkes, L Vu, T Watanabe, M Carossino, R Nabi, F Del Piero, ... Journal of virology 95 (3), 10.1128/jvi. 01359-20, 2021 | 17 | 2021 |
| Oral coadministration of an intramuscular DNA/modified vaccinia Ankara vaccine for simian immunodeficiency virus is associated with better control of infection in orally … AD Curtis, KA Walter, R Nabi, K Jensen, A Dwivedi, J Pollara, G Ferrari, ... AIDS research and human retroviruses 35 (3), 310-325, 2019 | 11 | 2019 |
| Intramuscular vaccination with the HSV-1 (VC2) live-attenuated vaccine strain confers protection against viral ocular immunopathogenesis associated with γδT cell intracorneal … R Nabi, AC Lewin, TM Collantes, VN Chouljenko, KG Kousoulas Frontiers in immunology 12, 789454, 2021 | 8 | 2021 |
| Bispecific anti-HIV immunoadhesins that bind Gp120 and Gp41 have broad and potent HIV-neutralizing activity SH Pincus, RB Craig, L Weachter, CC LaBranche, R Nabi, C Watt, ... Vaccines 9 (7), 774, 2021 | 7 | 2021 |
| The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro … R Nabi, F Musarrat, JC Menk P. Lima, IM Langohr, VN Chouljenko, ... Frontiers in Molecular Biosciences 10, 1199068, 2023 | 5 | 2023 |
| First impressions—the potential of altering initial host-virus interactions for rational design of herpesvirus vaccine vectors PJF Rider, F Musarrat, R Nabi, S Naidu, KG Kousoulas Current clinical microbiology reports 5, 55-65, 2018 | 4 | 2018 |
| Virus-like particles displaying trimeric SIV envelope gp160 enhance the breadth of DNA/MVA SIV vaccine induced antibody responses in rhesus macaques SS Iyer, S Gangadhara, B Victor, X Shen, X Chen, R Nabi J Virol 90, 8842-54, 2016 | 3 | 2016 |
| Adjuvanting an SIV vaccine with TLR ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5alpha restrictive macaques SP Kasturi, PA Kozlowski, HI Nakaya, MC Burger, P Russo, M Pham J Virol, 2016 | 3 | 2016 |
| AIDS Vaccine 2013October 7–10, 2013Barcelona, Spain T Hertz AIDS Research and Human Retroviruses 29 (11), A-1, 2013 | 1 | 2013 |
| Oncolytic virotherapy with the HSV-1 (VC2) vaccine strain induces anti-tumor T-cell responses in the murine 4T1 breast cancer model R Nabi, F Musarrat, V Chouljenko, K Kousoulas Cancer Research 82 (12_Supplement), 3572-3572, 2022 | | 2022 |
| 45724 VC2 Oncolytic Virotherapy Induces Robust Systemic Anti-Tumor Immunity and Increases Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model IK Uche, N Fowlkes, L Vu, T Watanabe, M Carossino, R Nabi, F Del Piero, ... Journal of Clinical and Translational Science 5 (s1), 13-14, 2021 | | 2021 |
| Cover Image, Volume 92, Number 10, October 2020 F Musarrat, V Chouljenko, A Dahal, R Nabi, T Chouljenko, SD Jois, ... Journal of Medical Virology 92 (10), i-i, 2020 | | 2020 |
